The lawyers at Saiontz & Kirk, P.A. have been investigating potential Digitek recall lawsuits for nearly a year on behalf of individuals who suffered digoxin toxicity after receiving oversized tablets. Now another generic drug maker has issued a digoxin recall involving pills that may contain too much of the medication,… Read more.
The attorneys at Saiontz & Kirk, P.A. have been investigating potential Digitek lawsuits since the generic heart drug was recalled in April 2008. Although Actavis has attempted to argue that none of the oversized tablets ever reached the public, according to reports of adverse events submitted to the FDA, there… Read more.
Following a series of recalls issued by Actavis this year, including a digoxin recall for all lots of their Digitek heart medication in May 2008, the U.S. House Committee on Energy and Commerce has requested additional information from the FDA about their oversight of the drug maker. This inquiry is… Read more.
Last week the United States Judicial Panel on Multidistrict Litigation ordered that any individual Digoxin lawsuit filed as a result of the April 2008 Digitek recall should be transferred to the Southern District of West Virginia. All cases will be consolidated for pretrial litigation and discovery before Judge Joseph R…. Read more.
On Monday, Actavis Totowa, LLC, the maker of Digitek, recalled over 65 different generic drugs made at their New Jersey manufacturing plant. Following an FDA inspection earlier this year, a number of violations of good manufacturing practices were identified. In April 2008, Actavis issued a Digitek recall for all lots… Read more.
The lawyers at Saiontz & Kirk, P.A. are investigating potential Digitek overdose lawsuits for individuals who experienced digitalis toxicity resulting in severe injuries or the need for medical treatment. Manufacturing defects allowed certain Digitek (digoxin) tablets to be sold with twice the appropriate amount of ingredient, increasing the risk of… Read more.
Less than two months after a Digitek recall was issued due to manufacturing problems that allowed double strength tablets to be commercially released, at least three lawsuits have been filed. A number of additional cases are expected to be filed in the coming weeks, as hundreds of potential cases are… Read more.
A nationwide Ethex morphine recall was issued yesterdat for 60 mg extended release morphine sulfate tablets. It was discovered that certain pills sold may contain up to double the appropriate medication and be twice as thick as normal. The recall lawyers at Saiontz & Kirk, P.A. are reviewing potential Ethex… Read more.
It has been over three weeks since a nationwide Digitek recall was issued after it was discovered that some tablets could contain twice the appropriate strength. However, very little information has been released about the extent of the Digitek problems and exactly how long double strength tablets have been sold.
Two weeks after a nationwide Digitek recall, several class action lawsuits have already been filed on behalf of users who took the heart drug. Manufacturing problems resulted in some tablets being sold with twice as much of the active medication as they were supposed to have. While Digitek class action… Read more.
